3.49
前日終値:
$3.28
開ける:
$3.31
24時間の取引高:
1.39M
Relative Volume:
1.38
時価総額:
$482.61M
収益:
-
当期純損益:
$-45.44M
株価収益率:
-9.9714
EPS:
-0.35
ネットキャッシュフロー:
$-42.28M
1週間 パフォーマンス:
+24.64%
1か月 パフォーマンス:
+9.06%
6か月 パフォーマンス:
+20.34%
1年 パフォーマンス:
+193.28%
Compass Therapeutics Inc Stock (CMPX) Company Profile
CMPX を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
CMPX
Compass Therapeutics Inc
|
3.49 | 435.59M | 0 | -45.44M | -42.28M | -0.35 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
392.05 | 99.76B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
579.61 | 62.21B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
452.33 | 59.14B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
ARGX
Argen X Se Adr
|
704.07 | 43.34B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
297.96 | 36.72B | 3.81B | -644.79M | -669.77M | -6.24 |
Compass Therapeutics Inc Stock (CMPX) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-07-01 | 再開されました | Raymond James | Outperform |
2025-04-02 | アップグレード | Leerink Partners | Market Perform → Outperform |
2025-02-24 | 開始されました | Guggenheim | Buy |
2025-02-19 | 開始されました | Piper Sandler | Overweight |
2024-12-23 | 開始されました | D. Boral Capital | Buy |
2024-11-15 | ダウングレード | Leerink Partners | Outperform → Market Perform |
2024-09-16 | アップグレード | Ladenburg Thalmann | Neutral → Buy |
2023-01-31 | 開始されました | Jefferies | Buy |
2023-01-27 | 開始されました | Stifel | Buy |
2022-05-23 | 再開されました | H.C. Wainwright | Buy |
2022-03-15 | 開始されました | Ladenburg Thalmann | Buy |
2022-01-19 | 開始されました | B. Riley Securities | Buy |
2021-12-22 | 開始されました | Raymond James | Outperform |
2021-12-20 | 開始されました | SVB Leerink | Outperform |
2021-12-15 | 開始されました | Wedbush | Outperform |
すべてを表示
Compass Therapeutics Inc (CMPX) 最新ニュース
What MACD and RSI say about Compass Therapeutics Inc.Market Growth Report & Growth Oriented Trade Recommendations - Newser
Applying sector rotation models to Compass Therapeutics Inc.Weekly Gains Report & Fast Exit Strategy with Risk Control - Newser
Smart tools for monitoring Compass Therapeutics Inc.’s price actionMarket Activity Report & Low Risk Growth Stock Ideas - Newser
Will earnings trigger a reversal in Compass Therapeutics Inc.Trade Risk Report & Free Real-Time Volume Trigger Notifications - Newser
Custom strategy builders for tracking Compass Therapeutics Inc.Global Markets & Consistent Profit Trading Strategies - Newser
Will Compass Therapeutics Inc. continue its uptrendIndex Update & Long-Term Growth Plans - Newser
How to escape a deep drawdown in Compass Therapeutics Inc.Oil Prices & Reliable Entry Point Trade Alerts - Newser
Statistical indicators supporting Compass Therapeutics Inc.’s strengthDay Trade & AI Driven Stock Price Forecasts - Newser
Multi asset correlation models including Compass Therapeutics Inc.2025 Trade Ideas & Accurate Buy Signal Notifications - Newser
Short interest data insights for Compass Therapeutics Inc.Earnings Overview Summary & Free High Return Stock Watch Alerts - Newser
Using Bollinger Bands to evaluate Compass Therapeutics Inc.Earnings Trend Report & Technical Buy Zone Confirmation - Newser
Will Compass Therapeutics Inc. benefit from macro trendsTrade Analysis Report & Fast Gain Stock Trading Tips - Newser
Is Compass Therapeutics Inc. stock bottoming outMarket Risk Report & Smart Allocation Stock Tips - Newser
Visualizing Compass Therapeutics Inc. stock with heatmapsJuly 2025 Selloffs & AI Enhanced Trading Alerts - Newser
What does recent volatility data suggest for Compass Therapeutics Inc.Weekly Earnings Recap & Daily Risk Controlled Trade Plans - Newser
Will Compass Therapeutics Inc. stock go up soonJuly 2025 PostEarnings & Weekly Market Pulse Alerts - Newser
Advanced analytics toolkit walkthrough for Compass Therapeutics Inc.Market Growth Summary & Free Expert Approved Momentum Trade Ideas - Newser
How sentiment analysis helps forecast Compass Therapeutics Inc.July 2025 Trends & Low Risk Growth Stock Ideas - Newser
Compass Therapeutics Inc. stock prediction for this weekLong Setup & Fast Entry and Exit Trade Plans - Newser
Can Compass Therapeutics Inc. hit a new high this monthQuarterly Market Review & Real-Time Sentiment Analysis - Newser
Technical analysis overview for Compass Therapeutics Inc. stockStop Loss & Free Weekly Watchlist of Top Performers - Newser
Is Compass Therapeutics Inc. forming a bottoming baseEarnings Miss & Safe Swing Trade Setups - Newser
Will Compass Therapeutics Inc. bounce back from current supportPortfolio Risk Report & Fast Exit and Entry Trade Guides - Newser
BTIG Raises Compass's PT to $11 from $9, Maintains Buy Rating - AInvest
Can volume confirm reversal in Compass Therapeutics Inc.Weekly Trend Summary & Low Risk High Win Rate Stock Picks - Newser
What MACD signals say about Compass Therapeutics Inc.Bond Market & Safe Entry Point Alerts - Newser
Heatmap analysis for Compass Therapeutics Inc. and competitorsWeekly Trade Recap & Precise Trade Entry Recommendations - Newser
Technical signs of recovery in Compass Therapeutics Inc.Trade Entry Summary & Long-Term Safe Return Strategies - Newser
Using portfolio simulators with Compass Therapeutics Inc. includedJuly 2025 Volume & Reliable Price Breakout Alerts - Newser
Compass Therapeutics to Participate in Upcoming September Investor Events - GlobeNewswire
Compass Therapeutics to Participate in Upcoming September Investor Events - GlobeNewswire Inc.
Intraday pattern recognizer results for Compass Therapeutics Inc.Trade Risk Report & Risk Controlled Daily Plans - Newser
Compass Therapeutics Inc (CMPX) 財務データ
収益
当期純利益
現金流量
EPS
Compass Therapeutics Inc (CMPX) インサイダートレーディング
インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
---|---|---|---|---|---|---|---|
GORDON CARL L | Director |
Apr 09 '25 |
Sale |
1.59 |
3,571,428 |
5,678,571 |
0 |
ORBIMED ADVISORS LLC | Director |
Apr 09 '25 |
Sale |
1.59 |
3,571,428 |
5,678,571 |
0 |
大文字化:
|
ボリューム (24 時間):